A popular drug used for diabetes and weight loss may also help protect the brain. That’s the key message from a new study ...

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which ...

A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and ...

The people who took semaglutide experienced a drop in their 10-year risk of developing atherosclerotic cardiovascular disease from 7.6% to 6.3% between the start of the study and the one-year mark ...

In this cohort study of adults prescribed semaglutide, initiation was associated with reductions in weight and cardiovascular risk ...

The road ahead As research into semaglutide’s effects on brain health continues, it is likely to open up new avenues for understanding and potentially treating Alzheimer’s disease.

Certain effects of semaglutide are already known to affect heart health directly, said Saad, who further pointed out that the drug “stabilizes atherosclerotic plaques, preventing the development ...

The unexpected heart benefits A groundbreaking meta-analysis has revealed semaglutide’s profound impact on cardiovascular health, demonstrating reductions across multiple risk factors.

Xu and colleagues reported an association between semaglutide use and a lower risk for opioid overdose during a 1-year follow-up compared with other antidiabetic medications — which included ...

2. Cardiovascular protection Semaglutide has been shown to reduce the risk of major cardiovascular events (such as heart attacks and strokes) in patients with type 2 diabetes.

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...